|
天大药业有限公司, 00455.HK - 综合损益表 |
2023-12 |
2022-12 |
2022-03 |
2021-03 |
2020-03 |
2019-03 |
2018-03 |
2017-03 |
2016-03 |
2015-03 |
2014-03 |
2013-03 |
2012-03 |
2011-03 |
2010-03 |
2009-03 |
2008-03 |
2007-03 |
2006-03 |
2005-03 |
营业额 |
532,089 |
410,021 |
509,955 |
474,332 |
491,475 |
527,003 |
361,555 |
195,539 |
192,785 |
139,367 |
247,173 |
180,214 |
97,277 |
103,661 |
82,951 |
56,936 |
36,304 |
19,970 |
15,208 |
10,113 |
经营溢利 |
-25,694 |
-47,890 |
-28,018 |
-27,442 |
15,928 |
26,167 |
29,942 |
32,750 |
18,425 |
-24,262 |
64,427 |
62,857 |
58,816 |
74,200 |
50,278 |
18,404 |
19,389 |
-135 |
4,731 |
-389 |
非经营/ 特殊项目 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-133,334 |
-20,680 |
0 |
-90 |
联营公司 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
658 |
924 |
3,859 |
-16,196 |
1,805 |
442 |
除税前经营溢利 |
-25,694 |
-47,890 |
-28,018 |
-27,442 |
15,928 |
26,167 |
29,942 |
32,750 |
18,425 |
-24,262 |
64,427 |
62,857 |
58,816 |
94,449 |
50,936 |
19,328 |
-110,085 |
-37,011 |
6,536 |
-38 |
税项 |
-689 |
-3,647 |
-6,343 |
-1,524 |
7,128 |
10,184 |
7,780 |
7,997 |
5,058 |
-1,245 |
15,477 |
12,098 |
14,847 |
14,675 |
10,244 |
5,638 |
2,831 |
56 |
52 |
45 |
少数股东权益 |
-850 |
-3,266 |
-1,904 |
1,224 |
5,657 |
13,326 |
12,154 |
12,310 |
6,799 |
-5,074 |
26,900 |
29,956 |
36,434 |
34,010 |
19,405 |
10,938 |
8,433 |
2,744 |
2,128 |
544 |
股东应占溢利 |
-24,155 |
-40,977 |
-19,771 |
-27,142 |
3,143 |
2,657 |
10,008 |
12,442 |
6,569 |
-17,942 |
22,050 |
37,740 |
43,096 |
67,426 |
21,287 |
2,752 |
-121,350 |
-39,811 |
4,355 |
-627 |
货币 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
单位 |
千 |
千 |
千 |
千 |
千 |
千 |
千 |
千 |
主要项目 |
折旧 |
0 |
37,687 |
22,149 |
20,618 |
19,520 |
19,587 |
0 |
0 |
0 |
0 |
17,928 |
19,408 |
23,694 |
2,458 |
3,254 |
3,587 |
3,157 |
2,883 |
2,122 |
1,681 |
利息 |
4,946 |
5,615 |
8,025 |
3,867 |
552 |
0 |
0 |
0 |
0 |
33 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
43 |
利息拨作发展资本 |
0 |
572 |
7,300 |
3,298 |
178 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
处置/重估固定资产 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
税率(%) |
2.68 |
7.62 |
22.64 |
5.55 |
44.75 |
38.92 |
25.98 |
24.42 |
27.45 |
5.13 |
24.02 |
19.25 |
25.24 |
15.54 |
20.11 |
29.17 |
|
|
0.8 |
|
营业额增长(%) |
29.77 |
0.0 |
7.51 |
-3.49 |
-6.74 |
45.76 |
84.9 |
1.43 |
38.33 |
-43.62 |
37.16 |
85.26 |
-6.16 |
24.97 |
45.69 |
56.83 |
81.79 |
31.31 |
50.38 |
75.39 |
股东应占溢利增长(%) |
41.05 |
0.0 |
27.16 |
0.0 |
18.28 |
-73.45 |
-19.57 |
89.42 |
0.0 |
-181.37 |
-41.58 |
-12.43 |
-36.09 |
216.75 |
673.58 |
|
|
|
|
|
核数师意见 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
说明:1代表无保留意见;2代表保留意见;3代表修改意见
|
|